69th DCC Recommends Mandatory Public Disclosure of Suspended and Cancelled Drug Licenses Vaayath Regulatory Desk | Drugs Consultative Committee, 69th Meeting | Held on 24.06.2026 The Drugs Consultative Committee (DCC), at its 69th meeting held on 24.06.2026, took up an…
Recent Post
- No Registration Certificate, No Entry for Imported Cosmetics
- CDSCO Clarifies Jurisdiction for Compounding of Offences Applications
- CDSCO Notifies Final Guidance Document on Medical Device Software (MDSW)
- When a “+” Sign Isn’t Just a Plus
- DCC intends to tighten control on manufacturing and supply of printed packaging materials used for drugs
